I wanna be the match

The other day in the mail I received my kit from the National Marrow Donor Program. I registered online early last week.

The instructions in the kit were simple enough—you just swab the inside of your cheek with the four enclosed cotton swabs and return them in the mail. There was no indication that I should brush my teeth first, or freshen up in any way, before swabbing my cheek. Once they process my swabs, my tissue type enters the system and the search for a match begins.

Being your average everyday white dude, a mostly 4th generation Swedish American, my background doesn't qualify me as being 'urgently needed' by the registry, but the brochure included with the kit is convincing, even inspiring. It includes pics of four pairs of people along with copy about how one of them donated to the other. It totally makes you wanna be the match.

IF I TURN OUT TO BE A MATCH

If I'm lucky, I will match someone in need of either PBSCs—peripheral blood stem cells—or bone marrow. The former is more likely, and for five days I would receive an injection that boosts production of PBSCs in my blood. Then I would be hooked up to a pair of IV's and—just like I did in college as a plasma donor—my blood would leave out of one side, and be returned, minus the PBSCs, in the other. Getting to the bone marrow will require anesthesia and a simple outpatient surgical procedure.

Peanuts compared to what the recipient faces: high-dose chemotherapy, relative isolation in a sterile environment, immunosuppressants, risk of graft-versus-host-disease (GVHD), and more.

IF YOU SHOULD BE THE MATCH

If you're interested in potentially being a match for a patient with a serious blood disorder in desperate need of peripheral stem cells or bone marrow, check out www.marrow.org.

It's like putting the organ donor sticker on your driver's license, except in this case you don't have to be a fatality to save another life.

By Ross Bonander
Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap